US Stock MarketDetailed Quotes

XTL Biopharmaceuticals (XTLB)

Watchlist
  • 2.445
  • +0.050+2.09%
Close Apr 14 16:00 ET
  • 2.445
  • 0.0000.00%
Post 20:01 ET
5.78MMarket Cap-0.68P/E (TTM)

XTL Biopharmaceuticals (XTLB) Balance Sheet

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q2)Jun 30, 2025
(FY)Dec 31, 2024
(Q4)Dec 31, 2024
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
Assets
Current assets
Cash, cash equivalents and short term investments
-83.67%259K
-43.02%1.14M
-43.02%1.14M
-22.03%1.72M
-33.45%1.59M
-18.67%2.34M
-46.09%2.01M
-46.09%2.01M
-49.72%2.21M
-53.78%2.38M
-Cash and cash equivalents
-74.75%150K
-73.52%371K
-73.52%371K
-43.72%820K
-62.62%594K
-43.91%1.07M
-33.09%1.4M
-33.09%1.4M
-34.55%1.46M
-32.27%1.59M
-Short-term investments
-89.01%109K
27.60%772K
27.60%772K
20.16%900K
24.94%992K
30.76%1.27M
-62.81%605K
-62.81%605K
-65.34%749K
-71.74%794K
Receivables
-70.39%90K
417.24%150K
417.24%150K
--140K
--304K
--150K
-59.15%29K
-59.15%29K
----
----
-Accounts receivable
--90K
--99K
--99K
--140K
----
----
--0
--0
----
----
-Loans receivable
----
----
----
----
--304K
--150K
----
----
----
----
-Other receivables
----
75.86%51K
75.86%51K
----
----
----
-59.15%29K
-59.15%29K
----
----
Prepaid assets
----
75.86%51K
75.86%51K
----
----
----
--29K
--29K
----
----
Other current assets
43.75%184K
327.27%47K
327.27%47K
64.94%127K
8.47%128K
-10.61%59K
-21.43%11K
-21.43%11K
-40.77%77K
-46.36%118K
Total current assets
-73.59%533K
-34.51%1.34M
-34.51%1.34M
-12.97%1.99M
-19.31%2.02M
-13.39%2.55M
-46.24%2.05M
-46.24%2.05M
-49.46%2.28M
-53.48%2.5M
Non current assets
Net PPE
--167K
--187K
--187K
--217K
----
----
--0
--0
----
----
Goodwill and other intangible assets
--0
1,744.47%7.01M
1,744.47%7.01M
1,762.11%7.08M
0.00%380K
0.00%380K
0.00%380K
0.00%380K
0.00%380K
0.00%380K
-Goodwill
--0
--3.19M
--3.19M
----
----
----
--0
--0
----
----
-Other intangible assets
----
904.21%3.82M
904.21%3.82M
----
----
----
0.00%380K
0.00%380K
----
----
Investments and advances
--14K
--14K
--14K
----
----
----
--0
--0
----
----
Total non current assets
-52.37%181K
1,797.37%7.21M
1,797.37%7.21M
1,819.21%7.29M
0.00%380K
0.00%380K
0.00%380K
0.00%380K
0.00%380K
-0.26%380K
Total assets
-70.23%714K
252.43%8.55M
252.43%8.55M
248.48%9.28M
-16.77%2.4M
-11.86%2.93M
-42.04%2.43M
-42.04%2.43M
-45.62%2.66M
-49.96%2.88M
Liabilities
Current liabilities
Payables
286.67%638K
22,600.00%227K
22,600.00%227K
241.98%554K
1.23%165K
-7.47%223K
-50.00%1K
-50.00%1K
--162K
--163K
-accounts payable
286.67%638K
19,500.00%196K
19,500.00%196K
241.98%554K
1.23%165K
-7.47%223K
-50.00%1K
-50.00%1K
--162K
--163K
-Other payable
----
--31K
--31K
----
----
----
----
----
----
----
Current accrued expenses
----
140.00%492K
140.00%492K
----
----
----
10.81%205K
10.81%205K
----
----
Current debt and capital lease obligation
--86K
--138K
--138K
--168K
----
----
----
----
----
----
-Current debt
--86K
--138K
--138K
--168K
----
----
----
----
----
----
Current deferred liabilities
----
--18K
--18K
----
----
----
--0
--0
----
----
Other current liabilities
--37K
--1.28M
--1.28M
--1.75M
----
----
----
----
----
----
Current liabilities
361.21%761K
971.36%2.21M
971.36%2.21M
1,422.84%2.47M
1.23%165K
-7.47%223K
10.16%206K
10.16%206K
5.88%162K
-5.23%163K
Non current liabilities
Non current deferred liabilities
--0
--219K
--219K
--331K
----
----
--0
--0
----
----
Derivative product liabilities
--0
--689K
--689K
--765K
----
----
--0
--0
----
----
Total non current liabilities
--0
--908K
--908K
--1.1M
--0
--0
--0
--0
--0
--0
Total liabilities
361.21%761K
1,412.14%3.12M
1,412.14%3.12M
2,099.38%3.56M
1.23%165K
-7.47%223K
10.16%206K
10.16%206K
5.88%162K
-15.98%163K
Shareholders'equity
Share capital
63.87%23.14M
63.87%23.14M
63.87%23.14M
63.87%23.14M
0.00%14.12M
0.00%14.12M
0.00%14.12M
0.00%14.12M
0.00%14.12M
0.00%14.12M
-common stock
63.87%23.14M
63.87%23.14M
63.87%23.14M
63.87%23.14M
0.00%14.12M
0.00%14.12M
0.00%14.12M
0.00%14.12M
0.00%14.12M
0.00%14.12M
Retained earnings
-3.95%-164.49M
-0.48%-159.01M
-0.48%-159.01M
-0.51%-158.77M
-0.31%-158.23M
-0.24%-157.76M
-1.14%-158.25M
-1.14%-158.25M
-1.44%-157.97M
-1.84%-157.75M
Paid-in capital
-3.44%141.29M
-3.44%141.29M
-3.44%141.29M
-3.42%141.33M
0.00%146.33M
0.00%146.33M
0.00%146.33M
0.00%146.33M
0.00%146.33M
0.00%146.33M
Gains losses not affecting retained earnings
0.00%20K
0.00%20K
0.00%20K
0.00%20K
0.00%20K
0.00%20K
0.00%20K
0.00%20K
0.00%20K
0.00%20K
Total stockholders'equity
-102.10%-47K
144.82%5.44M
144.82%5.44M
128.59%5.72M
-17.84%2.23M
-12.20%2.71M
-44.49%2.22M
-44.49%2.22M
-47.28%2.5M
-51.14%2.72M
Total equity
-102.10%-47K
144.82%5.44M
144.82%5.44M
128.59%5.72M
-17.84%2.23M
-12.20%2.71M
-44.49%2.22M
-44.49%2.22M
-47.28%2.5M
-51.14%2.72M
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
Unqualified Opinion with Explanatory Notes
--
--
--
--
Unqualified Opinion
--
--
--
(Q2)Jun 30, 2025(FY)Dec 31, 2024(Q4)Dec 31, 2024(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023
Assets
Current assets
Cash, cash equivalents and short term investments -83.67%259K-43.02%1.14M-43.02%1.14M-22.03%1.72M-33.45%1.59M-18.67%2.34M-46.09%2.01M-46.09%2.01M-49.72%2.21M-53.78%2.38M
-Cash and cash equivalents -74.75%150K-73.52%371K-73.52%371K-43.72%820K-62.62%594K-43.91%1.07M-33.09%1.4M-33.09%1.4M-34.55%1.46M-32.27%1.59M
-Short-term investments -89.01%109K27.60%772K27.60%772K20.16%900K24.94%992K30.76%1.27M-62.81%605K-62.81%605K-65.34%749K-71.74%794K
Receivables -70.39%90K417.24%150K417.24%150K--140K--304K--150K-59.15%29K-59.15%29K--------
-Accounts receivable --90K--99K--99K--140K----------0--0--------
-Loans receivable ------------------304K--150K----------------
-Other receivables ----75.86%51K75.86%51K-------------59.15%29K-59.15%29K--------
Prepaid assets ----75.86%51K75.86%51K--------------29K--29K--------
Other current assets 43.75%184K327.27%47K327.27%47K64.94%127K8.47%128K-10.61%59K-21.43%11K-21.43%11K-40.77%77K-46.36%118K
Total current assets -73.59%533K-34.51%1.34M-34.51%1.34M-12.97%1.99M-19.31%2.02M-13.39%2.55M-46.24%2.05M-46.24%2.05M-49.46%2.28M-53.48%2.5M
Non current assets
Net PPE --167K--187K--187K--217K----------0--0--------
Goodwill and other intangible assets --01,744.47%7.01M1,744.47%7.01M1,762.11%7.08M0.00%380K0.00%380K0.00%380K0.00%380K0.00%380K0.00%380K
-Goodwill --0--3.19M--3.19M--------------0--0--------
-Other intangible assets ----904.21%3.82M904.21%3.82M------------0.00%380K0.00%380K--------
Investments and advances --14K--14K--14K--------------0--0--------
Total non current assets -52.37%181K1,797.37%7.21M1,797.37%7.21M1,819.21%7.29M0.00%380K0.00%380K0.00%380K0.00%380K0.00%380K-0.26%380K
Total assets -70.23%714K252.43%8.55M252.43%8.55M248.48%9.28M-16.77%2.4M-11.86%2.93M-42.04%2.43M-42.04%2.43M-45.62%2.66M-49.96%2.88M
Liabilities
Current liabilities
Payables 286.67%638K22,600.00%227K22,600.00%227K241.98%554K1.23%165K-7.47%223K-50.00%1K-50.00%1K--162K--163K
-accounts payable 286.67%638K19,500.00%196K19,500.00%196K241.98%554K1.23%165K-7.47%223K-50.00%1K-50.00%1K--162K--163K
-Other payable ------31K--31K----------------------------
Current accrued expenses ----140.00%492K140.00%492K------------10.81%205K10.81%205K--------
Current debt and capital lease obligation --86K--138K--138K--168K------------------------
-Current debt --86K--138K--138K--168K------------------------
Current deferred liabilities ------18K--18K--------------0--0--------
Other current liabilities --37K--1.28M--1.28M--1.75M------------------------
Current liabilities 361.21%761K971.36%2.21M971.36%2.21M1,422.84%2.47M1.23%165K-7.47%223K10.16%206K10.16%206K5.88%162K-5.23%163K
Non current liabilities
Non current deferred liabilities --0--219K--219K--331K----------0--0--------
Derivative product liabilities --0--689K--689K--765K----------0--0--------
Total non current liabilities --0--908K--908K--1.1M--0--0--0--0--0--0
Total liabilities 361.21%761K1,412.14%3.12M1,412.14%3.12M2,099.38%3.56M1.23%165K-7.47%223K10.16%206K10.16%206K5.88%162K-15.98%163K
Shareholders'equity
Share capital 63.87%23.14M63.87%23.14M63.87%23.14M63.87%23.14M0.00%14.12M0.00%14.12M0.00%14.12M0.00%14.12M0.00%14.12M0.00%14.12M
-common stock 63.87%23.14M63.87%23.14M63.87%23.14M63.87%23.14M0.00%14.12M0.00%14.12M0.00%14.12M0.00%14.12M0.00%14.12M0.00%14.12M
Retained earnings -3.95%-164.49M-0.48%-159.01M-0.48%-159.01M-0.51%-158.77M-0.31%-158.23M-0.24%-157.76M-1.14%-158.25M-1.14%-158.25M-1.44%-157.97M-1.84%-157.75M
Paid-in capital -3.44%141.29M-3.44%141.29M-3.44%141.29M-3.42%141.33M0.00%146.33M0.00%146.33M0.00%146.33M0.00%146.33M0.00%146.33M0.00%146.33M
Gains losses not affecting retained earnings 0.00%20K0.00%20K0.00%20K0.00%20K0.00%20K0.00%20K0.00%20K0.00%20K0.00%20K0.00%20K
Total stockholders'equity -102.10%-47K144.82%5.44M144.82%5.44M128.59%5.72M-17.84%2.23M-12.20%2.71M-44.49%2.22M-44.49%2.22M-47.28%2.5M-51.14%2.72M
Total equity -102.10%-47K144.82%5.44M144.82%5.44M128.59%5.72M-17.84%2.23M-12.20%2.71M-44.49%2.22M-44.49%2.22M-47.28%2.5M-51.14%2.72M
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions --Unqualified Opinion with Explanatory Notes--------Unqualified Opinion------
Market Insights
China Concept Stocks
View More
Middle East conflict spreads to the stock market! How should investors respond?
US President Trump stated in a recent interview that the US war with Iran has 'ended.' According to Axios, Pakistan, Egypt, and Turkey have Show More